No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Alemtuzumab
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Murine-Derived
-
Antibodies, Neoplasm / therapeutic use
-
Antimetabolites, Antineoplastic / therapeutic use
-
Antineoplastic Agents / therapeutic use*
-
Bone Marrow Transplantation
-
Clinical Trials as Topic
-
Forecasting
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / classification
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Leukemia, Lymphocytic, Chronic, B-Cell / mortality
-
Leukemia, Lymphocytic, Chronic, B-Cell / therapy
-
Prognosis
-
Randomized Controlled Trials as Topic
-
Remission Induction
-
Rituximab
-
Vidarabine / analogs & derivatives
-
Vidarabine / therapeutic use
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Murine-Derived
-
Antibodies, Neoplasm
-
Antimetabolites, Antineoplastic
-
Antineoplastic Agents
-
Alemtuzumab
-
Rituximab
-
Vidarabine
-
fludarabine